Related references
Note: Only part of the references are listed.Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage
Naotaka Nishiyama et al.
CANCER SCIENCE (2010)
Genome-wide DNA methylation profiles in precancerous conditions and cancers
Yae Kanai
CANCER SCIENCE (2010)
DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status
Eri Arai et al.
EPIGENOMICS (2010)
Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome
Eri Arai et al.
CARCINOGENESIS (2009)
Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma
Eri Arai et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Genetics and epigenetics: stability and plasticity during cellular differentiation
Fabio Mohn et al.
TRENDS IN GENETICS (2009)
Tackling the methylome: recent methodological advances in genome-wide methylation profiling
Marcos R. H. Estecio et al.
GENOME MEDICINE (2009)
Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas
Wentao Gao et al.
CARCINOGENESIS (2008)
Alterations of DNA methylation and clinicopathological diversity of human cancers
Yae Kanai
PATHOLOGY INTERNATIONAL (2008)
Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state
Yae Kanai et al.
CARCINOGENESIS (2007)
Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas
Y. Sugino et al.
ONCOGENE (2007)
Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma
K. Tanaka et al.
ONCOGENE (2007)
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B
Yasnji Arase et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification
A Misawa et al.
CANCER RESEARCH (2005)
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
H Yoshida et al.
GUT (2004)
Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas
Y Saito et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades
Y Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis
Y Saito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A bacterial artificial chromosome library for sequencing the complete human genome
K Osoegawa et al.
GENOME RESEARCH (2001)
Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
H Kaneto et al.
GUT (2001)
Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma
Y Kondo et al.
HEPATOLOGY (2000)
Share Paper
